Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Donghoon Shin, Tae-Eun Kim, Seo Hyun Yoon, Joo-Youn Cho, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2012) Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects. Current Medical Research and Opinion 28:7, pages 1213-1220.
Read now
Read now
James E Foley & Jens Jordan. (2010) Weight neutrality with the DPP-4 inhibitor, vildagliptin: Mechanistic basis and clinical experience. Vascular Health and Risk Management 6, pages 541-548.
Read now
Read now
Lalit S Doshi, Manoja Kumar Brahma, Umakant A Bahirat, Amol V Dixit & Kumar VS Nemmani. (2010) Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents. Expert Opinion on Investigational Drugs 19:4, pages 489-512.
Read now
Read now
Francesco Chiarelli & Daniele Di Marzio. (2008) Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives. Vascular Health and Risk Management 4:2, pages 297-304.
Read now
Read now
Stanley Schwartz. (2008) Targeting the pathophysiology of type 2 diabetes: rationale for combination therapy with pioglitazone and exenatide. Current Medical Research and Opinion 24:11, pages 3009-3022.
Read now
Read now
Kenneth L Hastings. (2006) The use of hepatotoxic signals to predict the safety of peroxisome proliferator-activated receptor agonists. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 489-492.
Read now
Read now
Articles from other publishers (62)
Peter D Ahiawodzi, Jeremy D Furtado & Kenneth J Mukamal. (2022) Dietary Macronutrients and Circulating Nonesterified Fatty Acids: A Secondary Analysis of the OMNI Heart Crossover Trial. The Journal of Nutrition 152:12, pages 2802-2807.
Crossref
Crossref
Marcin Adamczak, Eberhard Ritz & Andrzej Wiecek. 2022. Nutritional Management of Renal Disease. Nutritional Management of Renal Disease
29
41
.
Rasoul Akbari, Tahereh Behdarvand, Reza Afarin, Hamid Yaghooti, Mohammad Taha Jalali & Narges Mohammadtaghvaei. (2021) Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. BMC Pharmacology and Toxicology 22:1.
Crossref
Crossref
Alan Chait & Laura J. den Hartigh. (2020) Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Frontiers in Cardiovascular Medicine 7.
Crossref
Crossref
Chao-Wei Huang, Tzu-Wen Hong, Ying-Jing Wang, Ko-Chien Chen, Ju-Chun Pei, Tai-Yuan Chuang, Wen-Sung Lai, Sheng-Hong Tsai, Richard Chu, Wei-Cheng Chen, Lee-Yan Sheen, Satoru Takahashi, Shih-Torng Ding & Tang-Long Shen. (2016) Ophiocordyceps formosana improves hyperglycemia and depression-like behavior in an STZ-induced diabetic mouse model. BMC Complementary and Alternative Medicine 16:1.
Crossref
Crossref
Wai Lau, Bey Goh, Habsah Kadir, Alexander Shu-Chien & Tengku Tengku Muhammad. (2015) Potent PPARγ Ligands from Swietenia macrophylla Are Capable of Stimulating Glucose Uptake in Muscle Cells. Molecules 20:12, pages 22301-22314.
Crossref
Crossref
Sudha S. Shankar, R. Ravi Shankar, Radha A. Railkar, Chan R. Beals, Helmut O. Steinberg & David E. Kelley. (2015) Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population. Current Therapeutic Research 77, pages 83-89.
Crossref
Crossref
Yanyan Sun, Jun Fan, Zhiyuan Zhu, Xiaodan Guo, Tingting Zhou, Wenhu Duan & Xu Shen. (2015) Small molecule TBTC as a new selective retinoid X receptor ? agonist improves behavioral deficit in Alzheimer's disease model mice. European Journal of Pharmacology 762, pages 202-213.
Crossref
Crossref
B. Wessels, J. Ciapaite, N. M. A. van den Broek, S. M. Houten, K. Nicolay & J. J. Prompers. (2015)
Pioglitazone treatment restores
in vivo
muscle oxidative capacity in a rat model of diabetes
. Diabetes, Obesity and Metabolism 17:1, pages 52-60.
Crossref
Crossref
Bianka Bojková, Peter Orendáš, Peter Kubatka, Martin Péč, Monika Kassayová, Terézia Kisková & Karol Kajo. (2014) Positive and negative effects of glitazones in carcinogenesis: Experimental models vs. clinical practice. Pathology - Research and Practice 210:8, pages 465-472.
Crossref
Crossref
Jean-Louis Guéant, Rania Elakoum, Olivier Ziegler, David Coelho, Eva Feigerlova, Jean-Luc Daval & Rosa-Maria Guéant-Rodriguez. (2013) Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart. Pflügers Archiv - European Journal of Physiology 466:5, pages 833-850.
Crossref
Crossref
Zhimin HuangXuesi WanJuan LiuWanping DengAiling ChenLiehua LiuJianbin LiuGuohong WeiHai LiDonghong FangYanbing Li. (2013) Short-Term Continuous Subcutaneous Insulin Infusion Combined with Insulin Sensitizers Rosiglitazone, Metformin, or Antioxidant α-Lipoic Acid in Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics 15:10, pages 859-869.
Crossref
Crossref
F J Steyn, T Y Xie, L Huang, S T Ngo, J D Veldhuis, M J Waters & C Chen. (2013) Increased adiposity and insulin correlates with the progressive suppression of pulsatile GH secretion during weight gain. Journal of Endocrinology 218:2, pages 233-244.
Crossref
Crossref
Joshua P. Taygerly, Lawrence R. McGee, Steven M. Rubenstein, Jonathan B. Houze, Timothy D. Cushing, Yang Li, Alykhan Motani, Jin-Long Chen, Walter Frankmoelle, Guosen Ye, Marc R. Learned, Juan Jaen, Shichang Miao, Pieter B. Timmermans, Martin Thoolen, Patrick Kearney, John Flygare, Holger Beckmann, Jennifer Weiszmann, Michelle Lindstrom, Nigel Walker, Jinsong Liu, Donna Biermann, Zhulun Wang, Atsushi Hagiwara, Tetsuya Iida, Hisateru Aramaki, Yuki Kitao, Hisashi Shinkai, Noboru Furukawa, Jun Nishiu & Motonao Nakamura. (2013) Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity. Bioorganic & Medicinal Chemistry 21:4, pages 979-992.
Crossref
Crossref
Eberhard Ritz, Marcin Adamczak & Andrzej Wiecek. 2013. Nutritional Management of Renal Disease. Nutritional Management of Renal Disease
17
30
.
Jialin Xu, Supriya R. Kulkarni, Ajay C. Donepudi, Vijay R. More & Angela L. Slitt. (2012) Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice. Diabetes 61:12, pages 3208-3218.
Crossref
Crossref
Lena Herbst, Matthias Goebel, Sebastian Bandholtz, Ronald Gust & Ulrich Kintscher. (2012) Characterization of Telmisartan-Derived PPAR? Agonists: Importance of Moiety Shift from Position?6 to?5 on Potency, Efficacy and Cofactor Recruitment. ChemMedChem 7:11, pages 1935-1942.
Crossref
Crossref
Hee-Oon Han, Jong-Sung Koh, Seung-Hae Kim, Ok-Ku Park, Kyoung-Hee Kim, Sang-Kweon Jeon, Gwong-Cheung Hur, Hyeon-Joo Yim & Geun-Tae Kim. (2012) Design and Synthesis of Oxime Ethers of ?-Oxo-?-phenylbutanoic Acids as PPAR ? and -? Dual Agonists. Bulletin of the Korean Chemical Society 33:6, pages 1979-1982.
Crossref
Crossref
Masataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato & Takao Nakamura. (2012) Lipoprotein lipase and obesity. Health 04:12, pages 1405-1412.
Crossref
Crossref
Yang Zhao, James D. Dunbar & Alexei Kharitonenkov. 2012. Endocrine FGFs and Klothos. Endocrine FGFs and Klothos
214
228
.
Joakim Håkansson, Björn Eliasson, Ulf Smith & Sven Enerbäck. (2011) Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone. Diabetology & Metabolic Syndrome 3:1.
Crossref
Crossref
Masataka Kusunoki, Kazuhiko Tsutsumi, Daisuke Sato, Aki Nakamura, Satoshi Habu, Yuichi Mori, Munehiko Morishita, Takayuki Yonemoto, Tetsuro Miyata, Yutaka Nakaya & Takao Nakamura. (2011) Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886. European Journal of Pharmacology 668:3, pages 486-491.
Crossref
Crossref
Guenther Boden. (2011) Obesity, insulin resistance and free fatty acids. Current Opinion in Endocrinology, Diabetes & Obesity 18:2, pages 139-143.
Crossref
Crossref
Minghan Wang. 2011. Metabolic Syndrome. Metabolic Syndrome
177
197
.
Miroslava Eckertova, Maria Ondrejcakova, Katarina Krskova, Stefan Zorad & Daniela Jezova. (2010) Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis. British Journal of Pharmacology 162:2, pages 452-463.
Crossref
Crossref
Yerra Koteswara Rao, Meng-Jen Lee, Keru Chen, Yi-Ching Lee, Wen-Shi Wu & Yew-Min Tzeng. (2011)
Insulin-Mimetic Action of Rhoifolin and Cosmosiin Isolated from
Citrus grandis
(L.) Osbeck Leaves: Enhanced Adiponectin Secretion and Insulin Receptor Phosphorylation in 3T3-L1 Cells
. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-9.
Crossref
Crossref
Mingyan Zhou, Aimin Xu, Karen S.L. Lam, Paul K.H. Tam, Chi-Ming Che, Lawrence Chan, In-Kyu Lee, Donghai Wu & Yu Wang. (2010) Rosiglitazone promotes fatty acyl CoA accumulation and excessive glycogen storage in livers of mice without adiponectin. Journal of Hepatology 53:6, pages 1108-1116.
Crossref
Crossref
R. Rabøl, R. Boushel, T. Almdal, C. N. Hansen, T. Ploug, S. B. Haugaard, C. Prats, S. Madsbad & F. Dela. (2010) Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes. Diabetes, Obesity and Metabolism 12:9, pages 806-814.
Crossref
Crossref
M. V. Tsvetkova, V. N. Khirmanov & N. N. Zybina. (2010) The role of nonesterified fatty acids in pathogenesis of cardiovascular diseases. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 16:1, pages 93-103.
Crossref
Crossref
Richard F. Hamman & Dana Dabelea. 2010. The Evidence Base for Diabetes Care. The Evidence Base for Diabetes Care
49
110
.
Meng-Jen Lee, Yerra Koteswara Rao, Keru Chen, Yi-Ching Lee & Yew-Min Tzeng. (2009) Effect of flavonol glycosides from Cinnamomum osmophloeum leaves on adiponectin secretion and phosphorylation of insulin receptor-β in 3T3-L1 adipocytes. Journal of Ethnopharmacology 126:1, pages 79-85.
Crossref
Crossref
Claudia C. Kaiser, Dinesh K. Shukla, Glenn T. Stebbins, Demetrios D. Skias, Douglas R. Jeffery, Dusan Stefoski, George Katsamakis & Douglas L. Feinstein. (2009) A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis. Journal of Neuroimmunology 211:1-2, pages 124-130.
Crossref
Crossref
Hao-Shu Wu, Di-Feng Zhu, Chang-Xin Zhou, Chu-Rui Feng, Yi-Jia Lou, Bo Yang & Qiao-Jun He. (2009) Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo. Journal of Ethnopharmacology 123:2, pages 288-292.
Crossref
Crossref
Guenther Boden. (2009) High- or Low-Carbohydrate Diets: Which Is Better for Weight Loss, Insulin Resistance, and Fatty Livers?. Gastroenterology 136:5, pages 1490-1492.
Crossref
Crossref
A. K. Gupta, S. R. Smith, F. L. Greenway & G. A. Bray. (2009) Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome. Diabetes, Obesity and Metabolism 11:4, pages 330-337.
Crossref
Crossref
Alykhan Motani, Zhulun Wang, Jennifer Weiszmann, Lawrence R. McGee, Gary Lee, Qingxiang Liu, Jocelyn Staunton, Zexu Fang, Helen Fuentes, Michelle Lindstrom, Jinsong Liu, Donna H.T. Biermann, Juan Jaen, Nigel P.C. Walker, R. Marc Learned, Jin-Long Chen & Yang Li. (2009) INT131: A Selective Modulator of PPARγ. Journal of Molecular Biology 386:5, pages 1301-1311.
Crossref
Crossref
Yusuke Moritoh, Koji Takeuchi, Tomoko Asakawa, Osamu Kataoka & Hiroyuki Odaka. (2009) The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. European Journal of Pharmacology 602:2-3, pages 448-454.
Crossref
Crossref
Brigitte Lankat-Buttgereit, Sabine Müller, Harald Schmidt, Klaus G. Parhofer, Thomas M. Gress & Rüdiger Göke. (2008) Knockdown of Pdcd4 results in induction of proprotein convertase 1/3 and potent secretion of chromogranin A and secretogranin II in a neuroendocrine cell line. Biology of the Cell 100:12, pages 703-715.
Crossref
Crossref
Guenther Boden. (2008) Obesity and Free Fatty Acids. Endocrinology and Metabolism Clinics of North America 37:3, pages 635-646.
Crossref
Crossref
Swapan K. Das, Winston S. Chu, Ashis K. Mondal, Neeraj K. Sharma, Philip A. Kern, Neda Rasouli & Steven C. Elbein. (2008) Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. American Journal of Physiology-Endocrinology and Metabolism 295:2, pages E393-E400.
Crossref
Crossref
Jill K. J. Gaidos, Bruce E. Hillner & Arun J. Sanyal. (2008) A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver International 28:5, pages 650-658.
Crossref
Crossref
David WrightLindsey Sutherland. (2008) Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance. Applied Physiology, Nutrition, and Metabolism 33:1, pages 21-31.
Crossref
Crossref
Angela Tesse, Ghassan Al-Massarani, Rosemary Wangensteen, Sebastien Reitenbach, M. Carmen Martínez & Ramaroson Andriantsitohaina. (2008) Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Prevents Microparticle-Induced Vascular Hyporeactivity through the Regulation of Proinflammatory Proteins. Journal of Pharmacology and Experimental Therapeutics 324:2, pages 539-547.
Crossref
Crossref
Paolo Calabro & Edward T. H. Yeh. (2008) Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight into global cardiometabolic risk. Current Hypertension Reports 10:1, pages 32-38.
Crossref
Crossref
Yehuda KAMARI, Ayelet HARARI, Aviv SHAISH, Edna PELEG, Yehonatan SHARABI, Dror HARATS & Ehud GROSSMAN. (2008) Effect of Telmisartan, Angiotensin II Receptor Antagonist, on Metabolic Profile in Fructose-Induced Hypertensive, Hyperinsulinemic, Hyperlipidemic Rats. Hypertension Research 31:1, pages 135-140.
Crossref
Crossref
Tianxin Yang & Sunhapas Soodvilai. (2008) Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention. PPAR Research 2008, pages 1-8.
Crossref
Crossref
Maria E Ramos-Nino, Charles D MacLean & Benjamin Littenberg. (2007) Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Medicine 5:1.
Crossref
Crossref
O. Schnell, G. Mertes & E. Standl. (2007) Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy. Diabetes, Obesity and Metabolism 9:6, pages 853-858.
Crossref
Crossref
Vishwajeet Puri, Silvana Konda, Srijana Ranjit, Myriam Aouadi, Anil Chawla, My Chouinard, Abhijit Chakladar & Michael P. Czech. (2007) Fat-specific Protein 27, a Novel Lipid Droplet Protein That Enhances Triglyceride Storage. Journal of Biological Chemistry 282:47, pages 34213-34218.
Crossref
Crossref
Bogdan Balas, Renata Belfort, Stephen A. Harrison, Celia Darland, Joan Finch, Steven Schenker, Amalia Gastaldelli & Kenneth Cusi. (2007) Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. Journal of Hepatology 47:4, pages 565-570.
Crossref
Crossref
Naveed Sattar, Alex McConnachie, Ian Ford, Allan Gaw, Stephen J. Cleland, Nita G. Forouhi, Peter McFarlane, James Shepherd, Stuart Cobbe & Chris Packard. (2007) Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study. Diabetes 56:4, pages 984-991.
Crossref
Crossref
Tina VilsbøllFilip K Knop. (2016) Review: DPP IV inhibitors - current evidence and future directions. The British Journal of Diabetes & Vascular Disease 7:2, pages 69-74.
Crossref
Crossref
A. J. Garber, A. Schweizer, M. A. Baron, E. Rochotte & S. Dejager. (2007) Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study. Diabetes, Obesity and Metabolism 9:2, pages 166-174.
Crossref
Crossref
Sudhakar Chintharlapalli, Sabitha Papineni & Stephen Safe. (2007)
1,1-Bis(3′-Indolyl)-1-(
p
-substitutedphenyl)methanes Inhibit Growth, Induce Apoptosis, and Decrease the Androgen Receptor in LNCaP Prostate Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Independent Pathways
. Molecular Pharmacology 71:2, pages 558-569.
Crossref
Crossref
Hee Oon Han, Seung Hae Kim, Kyoung-Hee Kim, Gwong-Cheung Hur, Hyeon Joo Yim, Hee-Kyung Chung, Sung Ho Woo, Ki Dong Koo, Chang-Seok Lee, Jong Sung Koh & Geun Tae Kim. (2007) Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists. Bioorganic & Medicinal Chemistry Letters 17:4, pages 937-941.
Crossref
Crossref
Paolo Calabro & Edward T. H. Yeh. (2008) Intra-abdominal adiposity, inflammation, and cardiovascular risk: New insight in the global cardiometabolic risk. Current Cardiovascular Risk Reports 1:1, pages 32-38.
Crossref
Crossref
Guenther Boden, Carol Homko, Maria Mozzoli, Meijuan Zhang, Karen Kresge & Peter Cheung. (2007) Combined Use of Rosiglitazone and Fenofibrate in Patients With Type 2 Diabetes. Diabetes 56:1, pages 248-255.
Crossref
Crossref
Kjeld Hermansen & Lene S Mortensen. (2007) Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus. Drug Safety 30:12, pages 1127-1142.
Crossref
Crossref
Catherine L. Martin. (2017) Case Study 1. The Diabetes Educator 33:1_suppl, pages 6S-13S.
Crossref
Crossref
Vivian A. Fonseca. (2007) Early identification and treatment of insulin resistance: Impact on subsequent prediabetes and type 2 diabetes. Clinical Cornerstone 8, pages S7-S18.
Crossref
Crossref
E A Pigarova & L K Dzeranova. (2006) Novye gorizonty primeneniya tiazolidindionov. Obesity and metabolism 3:4, pages 12-20.
Crossref
Crossref
Maria E. Trujillo & Philipp E. Scherer. (2006) Adipose Tissue-Derived Factors: Impact on Health and Disease. Endocrine Reviews 27:7, pages 762-778.
Crossref
Crossref